Store
At-Home Diagnostic Testing Markets and Trends, 2023
Publication Date: June 6, 2023
Tags: Coagulation, COVID-19, Diagnostic Instruments, In Vitro Diagnostics (IVD), Infectious Disease Testing Instruments, Point-of-Care (POC) Testing
Pages: 140
SKU: 23-720
Kalorama Information’s report, At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV, and Other Tests), 2023, delves into the expanding world of at-home and home collection tests. The at-home in vitro diagnostic (IVD) testing market comprises tests that can be purchased over the counter or online, where patients collect specimens and receive results within minutes, typically using lateral flow technology or dip stick methods. Meanwhile, the global home IVD testing market is burgeoning with potential. The home collection IVD testing market includes kits obtained from pharmacies or online, where patients collect specimens, send them to a lab for testing, and receive results back.
Key Features:
- Detailed market estimates by specialty, covering various segments such as cholesterol, drugs of abuse, fecal occult blood, glucose/HbA1c, infectious disease, COVID-19/flu/RSV, HIV, pregnancy and fertility, rapid coagulation, and genetic testing (excluding ancestry genetic testing)
- Market segmentation by venue: at-home test (patient gets result at home) and home collection test (sent to lab for results later)
- Analysis of trends and market dynamics driving the growth of at-home and home collection testing
- Forecasted market analysis for 2022-2027 based on demographic trends, technological advancements, and global expansion
- Insight into the evolution of consumer behavior toward healthcare and the rise of medical consumers seeking greater control over their health
Market Trends:
The report highlights the shift in consumer behavior toward healthcare, driven by a desire for greater control and access to personal health information. This shift has led to the growth of the home IVD testing market, with consumers becoming more cost-conscious and seeking early disease detection, personalized medicine, and more control over their health decisions. The report also discusses the impact of genetic testing on consumer awareness and the passage of the Genetic Information Nondiscrimination Act (GINA), which has encouraged consumers to explore their genetic makeup without fear of discrimination.
Why Buy This Report?
At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV, and Other Tests), 2023 provides a comprehensive overview of the evolving landscape of at-home and home collection testing. With detailed market estimates, analysis of key trends, and forecasts for the future, this report is an essential resource for businesses and stakeholders in the healthcare industry looking to understand and navigate the growing home testing market.
Table: Global At-Home IVD Market, by Sample Type, 2022 ($BN)
| Sample Type | Market Value |
| Blood | $XX Million |
| Urine | $XX Million |
| Oral/Saliva | $XX Million |
| Nasal | $XX Million |
| Stool | $XX Million |
| Other | $XX Million |
| Total At-Home IVD Market | $XX Million |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
Chapter 1: Executive Summary
Industry at a Glance
Scope and Methodology
Size and Growth of the Market
- Figure 1-1: Global Home IVD Market, by Key Segment (Glucose/HbA1c, COVID-19, Other, Genetic), 2019-2022
Key Issues and Trends Affecting the Market
Competitive Outlook
Conclusion Highlights
Chapter 2: Introduction
Overview
Issues and Trends
COVID-19
- Figure 2-1: Home COVID-19 Test Distribution of Sales by Vendor (Abbott Diagnostics, Becton Dickinson, OraSure Technologies, Siemens Healthineers, Quidel, Others)
Insurance for Home Tests
- Figure 2-2: Diabetes State Mandates – State-Level Insurance Mandates for Benefits, ACA Marketplace Coverage
Home IVD Testing Drivers and Challenges
- Figure 2-3: Benefits to Home Testing vs. Challenges in Home Testing
Genetics
- Table 2-1: Home Genetic Laboratory Testing, Market Drivers and Barriers
Home Collection
Chapter 3: At-Home IVD Tests
Introduction
Diabetes
- Table 3-1: Selected Glucose At-Home Testing Meter Innovations
Pregnancy and Fertility
Infectious Disease
HIV
COVID-19
COVID-19 & Flu
- Table 3-2: Selected COVID- 19 and COVID-19 & Flu A/B At-Home Tests for SARS-CoV-2
Coagulation
Fecal Occult Blood
Cholesterol
Drugs of Abuse
At-Home IVD Test Market by Test Type
- Table 3-3: Global At-Home IVD Market by Test Type (Glucose, Infectious Disease, Other), 2022 ($BN)
- Figure 3-1: Global At-Home IVD Market by Distribution of Sales by Segment (Glucose, COVID-19+, HIV, Other Infections, Cholesterol, Drug of Abuse, Coagulation, FOB, Pregnancy & Fertility, Other), 2022
At-Home IVD Tests Market by Sample Type
- Table 3-4: Global At-Home IVD Market by Sample Type (Blood, Nasal, Oral/Saliva, Stool, Urine, Other), 2022 ($BN)
- Figure 3-2: Global At-Home IVD Market by Distribution of Sales by Sample Type (Blood, Urine, Oral/Saliva, Nasal, Stool, Other), 2019 and 2022
- Figure 3-3: Year-over-Year Growth for At-Home IVD Markets (Cholesterol, Coagulation, COVID-19, Drugs of Abuse, FOB, Glucose, HIV, Other Infections, Pregnancy & Fertility, Other), 2020-2021 and 2021-2022 (%)
Blood Samples
- Figure 3-4: Estimated Distribution of Blood Sample Sales by Test Type (Cholesterol, Coagulation, Glucose, Other), 2022 (%)
Urine Samples
- Figure 3-5: Estimated Distribution of Urine Sample Sales, by Test Type (Drug of Abuse, Infectious Disease, Pregnancy, Other), 2022 (%)
Oral/Saliva Samples
- Figure 3-6: Estimated Distribution of Oral/Saliva Sample Sales by Test Type (COVID-19, Drug of Abuse, HIV, Other), 2022 (%)
Nasal Samples
- Figure 3-7: Estimated Distribution of Nasal Sample Sales by Test Type (COVID-19, Other), 2022 (%)
Stool Samples
- Figure 3-8: Estimated Distribution of Stool Sample Sales by Test Type (FOB, Other), 2022 (%)
Other
Chapter 4: Home Collection IVD Tests
Introduction
Pregnancy and Fertility
Infectious Disease
HIV
HPV and other STDs
COVID-19
COVID-19 & Flu
- Table 4-1: Selected Molecular EUA Tests for COVID-19
Fecal Occult Blood
Cholesterol
Genetics
Home Collection IVD Tests by Test Type
- Table 4-2: Global Home Collection IVD Market by Test Type (Genetics, Infectious Disease, Other Areas), 2022 ($BN)
- Figure 4-1: Global Home IVD Market by Distribution of Sales by Segment (Cholesterol, Coagulation, COVID-19, Drug of Abuse, Genetic, HbA1c, HIV, Other Infections, Pregnancy & Fertility, Other), 2022 (%)
Privacy
Home Collection Tests by Sample Type
- Table 4-3: Global Home Collection IVD Market by Sample Type (Blood, Nasal, Oral/Saliva, Stool, Urine, Other), 2022 ($BN)
- Figure 4-2: Global Home Collection IVD Market by Distribution of Sales by Sample Type (Blood, Urine, Oral/Saliva, Nasal, Stool, Other), 2019 and 2022
- Figure 4-3: Year-over-Year Growth for Home Collection IVD Markets, by Type (Cholesterol, Coagulation, COVID-19, Drug of Abuse, FOB, Genetic, HbA1c, HIV, Other Infections, Pregnancy & Fertility, Other), 2020-2021 and 2021-2022 (%)
Blood Samples
- Figure 4-4: Estimated Distribution of Blood Sample Sales by Test Type (Cholesterol, Fertility, Genetic, Glucose/HbA1c, Infectious Disease – STD blood spot, Tumor Market – PSA blood spot, Other – hormone), 2022 (%)
Urine Samples
- Figure 4-5: Estimated Distribution of Urine Sample Sales by Test Type (Infectious Disease – STD, Pregnancy/Fertility, Other – Heavy metals, hormone, nutrition), 2022 (%)
Oral/Saliva Samples
- Figure 4-6: Estimated Distribution of Oral/Saliva Sample Sales by Test Type (COVID-19, Drug of Abuse, Fertility, Genetic, HIV, Other – hormone, nutrition, medication match), 2022 (%)
Nasal Samples
- Figure 4-7: Estimated Distribution of Nasal Sample Sales by Test Type (COVID-19, Other), 2022 (%)
Stool Samples
- Figure 4-8: Estimated Distribution of Stool Sample Sales by Test Type (FOB, Infectious Disease – pathogen ID, Other – Heavy metals), 2022 (%)
Other
Chapter 5: Market Participants
23andMe, Inc
- Table 5-1: 23andMe Corporate Summary
Company Overview
- Table 5-2: 23andMe Genetic Tests with FDA Marketing Authorization
Performance Review
- Table 5-3: 23andMe Revenue, 2020-2022 ($ millions)
Abbott Diagnostics
- Table 5-4: Corporate Summary
Company Overview
Performance Review
- Table 5-5: Abbott Revenues, 2020-2022 (in millions $)
AccessBio, Inc.
- Table 5-6: AccessBio Corporate Summary
Company Overview
ACON Laboratories, Inc.
- Table 5-7: ACON Laboratories Corporate Summary
Company Overview
ARKRAY, Inc.
- Table 5-8: ARKRAY Corporate Summary
Company Overview
Ascensia Diabetes Care Holdings AG
- Table 5-9: Ascensia Diabetes Care Corporate Summary
Company Overview
Atomo Diagnostics
- Table 5-10: Atomo Corporate Summary
Company Overview
Performance Review
- Table 5-11: Atomo Revenues, 2021-2022 (in millions $)
Becton-Dickinson
- Table 5-12: Becton-Dickinson Corporate Summary
Company Overview
Performance Review
- Table 5-13: BD Corporation Revenue, 2020-2022 ($ millions)
binx health
- Table 5-14: binx health Corporate Summary
Company Overview
Biomerica, Inc.
- Table 5-15: Biomerica Corporate Summary
Company Overview
Company Financials
- Table 5-16: Biomerica Corporation Revenue, 2020-2022 ($ millions)
Biosynex SA
- Table 5-17: Biosynex Corporate Summary
Company Overview
Performance Review
- Table 5-18: Biosynex Revenues 2021-2022 (in millions $)
BTNX Inc.
- Table 5-19: BTNX Corporate Summary
Company Overview
Church & Dwight Co. Inc
- Table 5-20: Church & Dwight Corporate Summary
Company Overview
Performance Review
- Table 5-21: Church and Dwight Revenues, 2020-2022 ($ millions)
Color Health, Inc.
- Table 5-22: Color Health Corporate Summary
Company Overview
Cue Health
- Table 5-23: Cue Health Corporate Summary
Company Overview
Dexcom, Inc.
- Table 5-24: Dexcom Corporation Corporate Summary
Company Overview
Performance Review
- Table 5-25: Dexcom Revenues, 2020-2022 ($ millions)
EasyDNA
- Table 5-26: EasyDNA Corporate Summary
Company Overview
Everlywell
- Table 5-27: Everlywell Corporate Summary
Company Overview
Exact Sciences
- Table 5-28: Exact Sciences Corporate Summary
Company Overview
Performance Review
- Table 5-29: Exact Sciences Revenues, 2020-2022 ($ millions)
First Check Diagnostics LLC
- Table 5-30: First Check Diagnostics Corporate Summary
Company Overview
GlysBy diagnostics
- Table 5-31: GlysBy Corporate Summary
Company Overview
Helena Laboratories
- Table 5-32: Helena Laboratories Corporate Summary
Company Overview
Hemosure, Inc.
- Table 5-33: Hemosure Corporate Summary
Company Overview
LifeScan, Inc
- Table 5-34: LifeScan Corporate Summary
Company Overview
Medichecks.com Ltd.
- Table 5-35: Medichecks Corporate Summary
Company Overview
Myriad Genetics, Inc.
- Table 5-36: Myriad Genetics Corporate Summary
Company Overview
Performance Review
- Table 5-37: Myriad Diagnostics Revenue, 2020-2022 ($ millions)
OraSure Technologies, Inc.
- Table 5-38: OraSure Technologies Summary
Company Overview
Performance Review
- Table 5-39: OraSure Revenues, 2020-2022 ($ millions)
Polymedco, Inc
- Table 5-40: Polymedco Corporate Summary
Company Overview
Preventis GmbH
- Table 5-41: Preventis Corporate Summary
Company Overview
Prima Lab SA
- Table 5-42: Prima Corporate Summary
Company Overview
QuidelOrtho Corporation
- Table 5-43: QuidelOrtho Corporate Summary
Company Overview
Performance Review
- Table 5-44: QuidelOrtho Revenues, 2020-2022 ($ millions)
Roche Diagnostic Corporation
- Table 5-45: Roche Diagnostic Corporate Summary
Company Overview
Performance Review
- Table 5-46: Roche Diagnostics, 2020-2022 ($ millions)
Siemens Healthineers GmbH
- Table 5-47: Siemens Healthineers Corporate Summary
Company Overview
Performance Review
- Table 5-48: Siemens Healthineers, 2020-2022 ($ millions)
Swiss Precision Diagnostics GmbH
- Table 5-49: Swiss Precision Diagnostics Corporate Summary
Company Overview
Trividia Health
- Table 5-50: Trividia Health Corporate Summary
Company Overview
VedaLab
- Table 5-51: VedaLab Corporate Summary
Company Overview
Chapter 6: Market Analysis
Market Overview
- Figure 6-1: Global Home IVD Market, 2022-2027, 5% CAGR, ($MN)
Market Segment by Test Type
- Figure 6-2: Global Home IVD Market by Test Type (Genetic, Glucose/HbA1c, Infectious Disease, Other Areas), 2019-2022 ($MN)
- Figure 6-3: Global Home IVD Market, by General Test Segment (Genetic, Glucose/HbA1c, Infectious Disease, Other Areas), 2022
Glucose & HbA1c
- Table 6-1: Estimated Global Home IVD Glucose & HbA1c Testing Market, 2022-2027 $MN; CAGR 22-27
Infectious Disease
- Table 6-2: Estimated Global Home IVD Infectious Disease Testing Market, 2022-2027 $MN; CAGR 22-27
Other Areas
- Table 6-3: Estimated Global Home IVD Other Testing Market, 2022-2027 $MN; CAGR 22-27
Genetic
- Table 6-4: Estimated Global Home IVD Genetic Testing Market, 2022-2027 $MN; CAGR 22-27
Market by Distribution
Market by Region
- Figure 6-4: Estimated Global Home IVD Testing Market, by Region (APAC, EMEA, United States, Rest of World), 2019-2022
Competitive Analysis
- Figure 6-5: Estimated Global Home IVD Testing Market, Vendor Market Share, by Top Five Market Vendors (Abbott, Dexcom, QuidelOrtho, Roche, Siemens Healthineers, Other), 2022
Related products
In Vitro Diagnostic (IVD) Trends and Market Update: November 2023
November 7, 2023
As in vitro diagnostic (IVD) testing returns to its vital role in healthcare, it remains a cornerstone in medical practice, providing crucial insights for physicians, from diagnosis to precision medicine. While COVID-19 testing sees a decline, it continues to influence total revenues for 2023. In this ever-changing landscape, characterized by new products, shifts in global…
Price range: $3,750.00 through $5,625.00
30-Country In Vitro Diagnostic (IVD) Market Atlas [October 2023 Update]
October 27, 2023
The in vitro diagnostics (IVD) market is a global multi-billion-dollar industry, with significant revenue generated outside the United States. To facilitate successful business planning, it’s crucial to assess regional and country-level IVD markets. Kalorama’s 30 Country IVD Market Atlas report offers detailed insights into international markets, aiding in forecast modeling and strategic planning.
Key…
Price range: $5,000.00 through $7,500.00
Cell Therapy and Gene Therapy Disease Markets, 2023-2029
April 30, 2024
Explore the future of medicine with our in-depth report on cell therapy, gene therapy, and RNA therapy markets. Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body’s immune system. Recent years have seen an increase in…
Price range: $5,000.00 through $7,875.00
